267 related articles for article (PubMed ID: 28677090)
1. Klotho levels: association with insulin resistance and albumin-to-creatinine ratio in type 2 diabetic patients.
Silva AP; Mendes F; Pereira L; Fragoso A; Gonçalves RB; Santos N; Rato F; Neves PL
Int Urol Nephrol; 2017 Oct; 49(10):1809-1814. PubMed ID: 28677090
[TBL] [Abstract][Full Text] [Related]
2. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
[TBL] [Abstract][Full Text] [Related]
3. FGF23-klotho axis as predictive factors of fractures in type 2 diabetics with early chronic kidney disease.
Ribeiro AL; Mendes F; Carias E; Rato F; Santos N; Neves PL; Silva AP
J Diabetes Complications; 2020 Jan; 34(1):107476. PubMed ID: 31708378
[TBL] [Abstract][Full Text] [Related]
4. Soluble Klotho and fibroblast growth factor 23 levels in diabetic nephropathy with different stages of albuminuria.
Inci A; Sari F; Coban M; Olmaz R; Dolu S; Sarıkaya M; Yılmaz N
J Investig Med; 2016 Aug; 64(6):1128-33. PubMed ID: 27323770
[TBL] [Abstract][Full Text] [Related]
5. Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A.
Kacso IM; Bondor CI; Kacso G
Clin Biochem; 2012 Nov; 45(16-17):1415-20. PubMed ID: 22836100
[TBL] [Abstract][Full Text] [Related]
6. Circulating Levels of Soluble Klotho and Fibroblast Growth Factor 23 in Diabetic Patients and Its Association with Early Nephropathy.
Farías-Basulto A; Martínez-Ramírez HR; Gómez-García EF; Cueto-Manzano AM; Cortés-Sanabria L; Hernández-Ramos LE; Ramírez-López G; Mendoza-Carrera F
Arch Med Res; 2018 Oct; 49(7):451-455. PubMed ID: 30718148
[TBL] [Abstract][Full Text] [Related]
7. Plasmatic Klotho and FGF23 Levels as Biomarkers of CKD-Associated Cardiac Disease in Type 2 Diabetic Patients.
Silva AP; Mendes F; Carias E; Gonçalves RB; Fragoso A; Dias C; Tavares N; Café HM; Santos N; Rato F; Leão Neves P; Almeida E
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934737
[TBL] [Abstract][Full Text] [Related]
8. Circulating α-klotho levels in CKD and relationship to progression.
Kim HR; Nam BY; Kim DW; Kang MW; Han JH; Lee MJ; Shin DH; Doh FM; Koo HM; Ko KI; Kim CH; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH
Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260
[TBL] [Abstract][Full Text] [Related]
9. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
[TBL] [Abstract][Full Text] [Related]
10. Decreased plasma α-Klotho predict progression of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Lee EY; Lee SM; Chung CH; Kwak IS; Lee EK; Kim YK
J Diabetes Complications; 2016 Jul; 30(5):887-92. PubMed ID: 27037042
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor-23 is a strong predictor of insulin resistance among chronic kidney disease patients.
Fayed A; El Nokeety MM; Heikal AA; Abdulazim DO; Naguib MM; Sharaf El Din UAA;
Ren Fail; 2018 Nov; 40(1):226-230. PubMed ID: 29619868
[TBL] [Abstract][Full Text] [Related]
12. In chronic kidney disease, serum α-Klotho is related to serum bicarbonate and proteinuria.
Hage V; Pelletier S; Dubourg L; Drai J; Cuerq C; Lemoine S; Hadj-Aissa A; Laville M; Fouque D
J Ren Nutr; 2014 Nov; 24(6):390-4. PubMed ID: 25193108
[TBL] [Abstract][Full Text] [Related]
13. Relationship between cFGF23/Klotho ratio and phosphate levels in patients with chronic kidney disease.
Liu Z; Zhou H; Chen X; Chen H; Wang Y; Wang T; Cai L; Hong Y; Ke H; Zheng J
Int Urol Nephrol; 2019 Mar; 51(3):503-507. PubMed ID: 30689182
[TBL] [Abstract][Full Text] [Related]
14. Altered serum levels of FGF-23 and magnesium are independent risk factors for an increased albumin-to-creatinine ratio in type 2 diabetics with chronic kidney disease.
Silva AP; Mendes F; Fragoso A; Jeronimo T; Pimentel A; Gundlach K; Büchel J; Santos N; Neves PL
J Diabetes Complications; 2016 Mar; 30(2):275-80. PubMed ID: 26750742
[TBL] [Abstract][Full Text] [Related]
15. Soluble Klotho levels in diabetic nephropathy: relationship with arterial stiffness.
Inci A; Sari F; Olmaz R; Coban M; Dolu S; Sarikaya M; Ellidag HY
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(15):3230-7. PubMed ID: 27466997
[TBL] [Abstract][Full Text] [Related]
16. Soluble α-klotho and its relation to kidney function and fibroblast growth factor-23.
Scholze A; Liu Y; Pedersen L; Xia S; Roth HJ; Hocher B; Rasmussen LM; Tepel M
J Clin Endocrinol Metab; 2014 May; 99(5):E855-61. PubMed ID: 24606097
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.
Wan M; Smith C; Shah V; Gullet A; Wells D; Rees L; Shroff R
Nephrol Dial Transplant; 2013 Jan; 28(1):153-61. PubMed ID: 23180879
[TBL] [Abstract][Full Text] [Related]
18. Randomized Clinical Trial of Sevelamer Carbonate on Serum Klotho and Fibroblast Growth Factor 23 in CKD.
Liabeuf S; Ryckelynck JP; El Esper N; Ureña P; Combe C; Dussol B; Fouque D; Vanhille P; Frimat L; Thervet E; Mentaverri R; Prié D; Choukroun G;
Clin J Am Soc Nephrol; 2017 Dec; 12(12):1930-1940. PubMed ID: 29074818
[TBL] [Abstract][Full Text] [Related]
19. The FGF-23/klotho axis and its relationship with phosphorus, calcium, vitamin D, PTH, aldosterone, severity of disease, and outcome in hospitalised foals.
Kamr AM; Dembek KA; Hildreth BE; Morresey PR; Rathgeber RA; Burns TA; Zaghawa AA; Toribio RE
Equine Vet J; 2018 Nov; 50(6):739-746. PubMed ID: 29660161
[TBL] [Abstract][Full Text] [Related]
20. Plasma s-Klotho is related to kidney function and predicts adverse renal outcomes in patients with advanced chronic kidney disease.
Liu QF; Ye JM; Yu LX; He AL; Sun Q; He DW; Li SS
J Investig Med; 2018 Mar; 66(3):669-675. PubMed ID: 29061648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
